Eye movements may reveal Parkinson's progression

NCT ID NCT04731246

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 30 people with mild-to-moderate Parkinson's disease for up to 7 years. Researchers use a video eye-tracking device to measure eye movements and compare them with standard neurological and cognitive tests. The goal is to see if eye-tracking can serve as a reliable marker of disease progression. Participants must have a confirmed Parkinson's diagnosis and no major eye movement problems at the start.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE, IDIOPATHIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Centre Mémoire / Centre de Gérontologie Clinique Rainier III / Princess Grace Hospital

    RECRUITING

    Monaco, 98000, Monaco

    Contact Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.